2022
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old
Guillot J, Rentsch CT, Gordon KS, Justice AC, Bezin J. Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old. Pharmacoepidemiology And Drug Safety 2022, 31: 1056-1074. PMID: 35780391, PMCID: PMC9464694, DOI: 10.1002/pds.5506.Peer-Reviewed Original ResearchConceptsLevel of polypharmacyRace/ethnicityPIM prevalencePrevalence of PIMsInappropriate medication useElectronic health recordsCommon PIMsPharmacy fillsPROMPT criteriaInappropriate medicationsOlder patientsMedication usePsychotropic medicationsRefill recordsPolypharmacyPatientsVeterans AffairsMedicationsPrevalenceHealth recordsFiscal year 2016AgeMeaningful differencesSexTarget ageComparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform
Williamson E, Tazare J, Bhaskaran K, McDonald H, Walker A, Tomlinson L, Wing K, Bacon S, Bates C, Curtis H, Forbes H, Minassian C, Morton C, Nightingale E, Mehrkar A, Evans D, Nicholson B, Leon D, Inglesby P, MacKenna B, Davies N, DeVito N, Drysdale H, Cockburn J, Hulme W, Morley J, Douglas I, Rentsch C, Mathur R, Wong A, Schultze A, Croker R, Parry J, Hester F, Harper S, Grieve R, Harrison D, Steyerberg E, Eggo R, Diaz-Ordaz K, Keogh R, Evans S, Smeeth L, Goldacre B. Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform. Diagnostic And Prognostic Research 2022, 6: 6. PMID: 35197114, PMCID: PMC8865947, DOI: 10.1186/s41512-022-00120-2.Peer-Reviewed Original ResearchCOVID-19-related deathsInfection prevalenceOpenSAFELY platformGeneral populationNational Statistics mortality dataNumber of comorbiditiesRisk prediction toolsAbsolute risk estimationStatistics mortality dataAbsolute risk estimatesCase-cohort sampleRisk prediction modelTarget populationElectronic health record systemsPrimary careCOVID-19 casesGeneral practiceEmergency careHealth record systemsLocal infection prevalenceNHS EnglandBasic demographicsPrevalenceMortality dataRisk estimates
2021
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
Grint D, Wing K, Williamson E, McDonald H, Bhaskaran K, Evans D, Evans S, Walker A, Hickman G, Nightingale E, Schultze A, Rentsch C, Bates C, Cockburn J, Curtis H, Morton C, Bacon S, Davy S, Wong A, Mehrkar A, Tomlinson L, Douglas I, Mathur R, Blomquist P, MacKenna B, Ingelsby P, Croker R, Parry J, Hester F, Harper S, DeVito N, Hulme W, Tazare J, Goldacre B, Smeeth L, Eggo R. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Eurosurveillance 2021, 26: 2100256. PMID: 33739254, PMCID: PMC7976383, DOI: 10.2807/1560-7917.es.2021.26.11.2100256.Peer-Reviewed Original Research
2020
Study protocol: Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform
Williamson E, Tazare J, Bhaskaran K, Walker A, McDonald H, Tomlinson L, Bacon S, Bates C, Curtis H, Forbes H, Minassian C, Morton C, Nightingale E, Mehrkar A, Evans D, Nicholson B, Leon D, Inglesby P, MacKenna B, Cockburn J, Davies N, Hulme W, Morley J, Douglas I, Rentsch C, Mathur R, Wong A, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Grieve R, Harrison D, Steyerberg E, Eggo R, Diaz-Ordaz K, Keogh R, Evans S, Smeeth L, Goldacre B. Study protocol: Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform. Wellcome Open Research 2020, 5: 243. DOI: 10.12688/wellcomeopenres.16353.1.Peer-Reviewed Original ResearchRisk prediction modelPrimary care electronic health record dataCOVID-19Chronic disease settingsElectronic health record dataHealth record dataPrevalence of infectionCOVID-19 deathsWorld Health OrganizationOpenSAFELY platformAdult patientsPoor outcomeInfection burdenDisease settingsDeath dataInfectious diseasesHealth OrganizationInfection prevalenceRecord dataCohort approachPopulation of interestPrevalenceTime-varying measuresDeathOutcomes